Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2

NAActive, not recruitingINTERVENTIONAL
Enrollment

747

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
HIV
Interventions
BEHAVIORAL

Disclosure intervention

Participants who are assigned to the Sankofa intervention will take part in the process of disclosure (pre-disclosure, disclosure, and post-disclosure phases) with the adherence and disclosure specialist (ADDS).

BEHAVIORAL

Usual Care

During the control period, patients and caregivers recruited at the clinics will receive the current practice in the clinic, where the health care provider is expected to assess the caregiver and child readiness for disclosure during clinic appointments and give some information as they think indicated.

Trial Locations (1)

Unknown

Korle-Bu Teaching Hospital, Accra

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Boston University

OTHER